197 related articles for article (PubMed ID: 35430257)
1. Discovery of mycotoxin alternariol as a potential lead compound targeting xanthine oxidase.
Fan J; Sun S; Lv C; Li Z; Guo M; Yin Y; Wang H; Wang W
Chem Biol Interact; 2022 Jun; 360():109948. PubMed ID: 35430257
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of 1-alkyl-5/6-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1H-indole-3-carbonitriles as novel xanthine oxidase inhibitors.
Gao J; Liu X; Zhang B; Mao Q; Zhang Z; Zou Q; Dai X; Wang S
Eur J Med Chem; 2020 Mar; 190():112077. PubMed ID: 32014678
[TBL] [Abstract][Full Text] [Related]
3. In vitro xanthine oxidase inhibitory and in vivo anti-hyperuricemic properties of sodium kaempferol-3'-sulfonate.
Wang X; Cui Z; Luo Y; Huang Y; Yang X
Food Chem Toxicol; 2023 Jul; 177():113854. PubMed ID: 37230458
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of N-(3-cyano-1H-indol-5/6-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamides and 5-(6-oxo-1,6-dihydropyrimidin-2-yl)-1H-indole-3-carbonitriles as novel xanthine oxidase inhibitors.
Zhang B; Duan Y; Yang Y; Mao Q; Lin F; Gao J; Dai X; Zhang P; Li Q; Li J; Dai R; Wang S
Eur J Med Chem; 2022 Jan; 227():113928. PubMed ID: 34688012
[TBL] [Abstract][Full Text] [Related]
5. 3,4-Dihydroxy-5-nitrobenzaldehyde (DHNB) is a potent inhibitor of xanthine oxidase: a potential therapeutic agent for treatment of hyperuricemia and gout.
Lü JM; Yao Q; Chen C
Biochem Pharmacol; 2013 Nov; 86(9):1328-37. PubMed ID: 23994369
[TBL] [Abstract][Full Text] [Related]
6. Potential xanthine oxidase inhibitory activity of endophytic Lasiodiplodia pseudotheobromae.
Kapoor N; Saxena S
Appl Biochem Biotechnol; 2014 Jul; 173(6):1360-74. PubMed ID: 24801403
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Xanthine Oxidase by 4-nitrocinnamic Acid:
Chen J; Yu S; He Z; Zhu D; Cai X; Ruan Z; Jin N
Curr Pharm Biotechnol; 2024; 25(4):477-487. PubMed ID: 37345239
[TBL] [Abstract][Full Text] [Related]
8.
Gul A; Saad SM; Zafar H; Atia-Tul-Wahab ; Khan KM; Choudhary MI
Med Chem; 2023; 19(4):384-392. PubMed ID: 35726432
[TBL] [Abstract][Full Text] [Related]
9. Probing the Interactions of 31 Mycotoxins with Xanthine Oxidase: Alternariol, Alternariol-3-Sulfate, and α-Zearalenol Are Allosteric Inhibitors of the Enzyme.
Balázs O; Dombi Á; Zsidó BZ; Hetényi C; Vida RG; Poór M
Toxins (Basel); 2023 Mar; 15(4):. PubMed ID: 37104188
[TBL] [Abstract][Full Text] [Related]
10. Novel 3-[4-alkoxy-3-(1H-tetrazol-1-yl) phenyl]-1,2,4-oxadiazol-5(4H)-ones as promising xanthine oxidase inhibitors: Design, synthesis and biological evaluation.
Gao J; Zhang Z; Zhang B; Mao Q; Dai X; Zou Q; Lei Y; Feng Y; Wang S
Bioorg Chem; 2020 Jan; 95():103564. PubMed ID: 31927335
[TBL] [Abstract][Full Text] [Related]
11. Chalcone derivatives as xanthine oxidase inhibitors: synthesis, binding mode investigation, biological evaluation, and ADMET prediction.
Yang C; Liu Y; Tu Y; Li L; Du J; Yu D; He P; Wang T; Liu Y; Chen H; Li Y
Bioorg Chem; 2023 Feb; 131():106320. PubMed ID: 36527991
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of thiazolidine-2-thione derivatives as novel xanthine oxidase inhibitors.
Wang MX; Qin HW; Liu C; Lv SM; Chen JS; Wang CG; Chen YY; Wang JW; Sun JY; Liao ZX
PLoS One; 2022; 17(5):e0268531. PubMed ID: 35584139
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, molecular docking and xanthine oxidase inhibitory activity of 5-aryl-1H-tetrazoles.
Fatima I; Zafar H; Khan KM; Saad SM; Javaid S; Perveen S; Choudhary MI
Bioorg Chem; 2018 Sep; 79():201-211. PubMed ID: 29772470
[TBL] [Abstract][Full Text] [Related]
14. Xanthine oxidase inhibitory activity of nicotino/isonicotinohydrazides: A systematic approach from in vitro, in silico to in vivo studies.
Zafar H; Hayat M; Saied S; Khan M; Salar U; Malik R; Choudhary MI; Khan KM
Bioorg Med Chem; 2017 Apr; 25(8):2351-2371. PubMed ID: 28302506
[TBL] [Abstract][Full Text] [Related]
15. Xanthine oxidase inhibition study of isolated secondary metabolites from
Nguyen DK; Liu TW; Hsu SJ; Huynh QT; Thi Duong TL; Chu MH; Wang YH; Vo TH; Lee CK
Saudi Pharm J; 2024 Apr; 32(4):101980. PubMed ID: 38439949
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of hydroxychalcones as multifunctional non-purine xanthine oxidase inhibitors for the treatment of hyperuricemia.
Xie Z; Luo X; Zou Z; Zhang X; Huang F; Li R; Liao S; Liu Y
Bioorg Med Chem Lett; 2017 Aug; 27(15):3602-3606. PubMed ID: 28655421
[TBL] [Abstract][Full Text] [Related]
17. Hypouricaemic action of mangiferin results from metabolite norathyriol via inhibiting xanthine oxidase activity.
Niu Y; Liu J; Liu HY; Gao LH; Feng GH; Liu X; Li L
Pharm Biol; 2016 Sep; 54(9):1680-6. PubMed ID: 26916555
[TBL] [Abstract][Full Text] [Related]
18. Xanthine oxidase inhibitory kinetics and mechanism of ellagic acid: In vitro, in silico and in vivo studies.
Chen J; He Z; Yu S; Cai X; Zhu D; Lin Y
IET Nanobiotechnol; 2023 Jun; 17(4):368-375. PubMed ID: 37153957
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, structure-activity relationships, and mechanistic studies of 5-arylazo-tropolone derivatives as novel xanthine oxidase (XO) inhibitors.
Sato D; Kisen T; Kumagai M; Ohta K
Bioorg Med Chem; 2018 Jan; 26(2):536-542. PubMed ID: 29274704
[TBL] [Abstract][Full Text] [Related]
20. Dinuclear Cyclam Complex as a Non-Cytotoxic, Anti-Hyperurecemic Lead: In vitro to In vivo Studies.
Zafar H; Hamdi N; Lachkar M; El Bali B; Khan A; Choudhary MI
Med Chem; 2017; 13(6):585-591. PubMed ID: 28290251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
